PNEUMOCOCCAL

(PCV13- PREVNAR13) VACCINE

VACCINE USAGE: active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F and for the prevention of otitis media caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F. Prevnar 13 is approved for use in children 6 weeks through 5 years of age.

VACCINE DOSAGE: suspension for intramuscular 0.5 mL dose injection.

IN CHILDREN 6 WEEKS THROUGH 5 YEARS OF AGE PREVNAR 13 IS INDICATED FOR:

  • active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F.
  • active immunization for the prevention of otitis media caused by S. pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F. No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A.

IN CHILDREN 6 YEARS THROUGH 17 YEARS OF AGE PREVNAR 13 IS INDICATED FOR:

  • active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F.

IN ADULTS 18 YEARS OF AGE AND OLDER, PREVNAR 13 IS INDICATED FOR:

  • active immunization for the prevention of pneumonia and invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F.

LIMITATIONS OF PREVNAR 13 USE AND EFFECTIVENESS:

  • Prevnar 13 does not protect against disease caused by S. pneumoniae serotypes that are not in the vaccine.

VACCINE INGEDIENTS: casamino acids, yeast, ammonium sulfate, polysorbate 80, succinate suffer, aluminum phosphate.

ADVERSE VACCINE REACTIONS: bronchiolitis, gastroenteritis, pneumonia, sudden infant death syndrome (SIDS), fever, decreased appetite, irritability, increased or decreased sleep, diarrhea, vomiting, rash, inconsolable crying, hypersensitivity, seizures, urticaria, anaphylactic/ anaphylactoid reaction including shock, apnea.